Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus.
Oncotarget
Lim, Sun Min SM; Park, Hyung Soon HS; Kim, Sangwoo S; Kim, Sora S; Ali, Siraj M SM; Greenbowe, Joel R JR; Yang, In Seok IS; Kwon, Nak-Jung NJ; Lee, Jae Lyun JL; Ryu, Min-Hee MH; Ahn, Jin-Hee JH; Lee, Jeeyun J; Lee, Min Goo MG; Kim, Hyo Song HS; Kim, Hyunki H; Kim, Hye Ryun HR; Moon, Yong Wha YW; Chung, Hyun Cheol HC; Kim, Joo-Hang JH; Kang, Yoon-Koo YK; Cho, Byoung Chul BC